These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36741012)

  • 1. Lobaplatin-based prophylactic hyperthermic intraperitoneal chemotherapy for T4 gastric cancer patients: A retrospective clinical study.
    Zhong Y; Kang W; Hu H; Li W; Zhang J; Tian Y
    Front Oncol; 2023; 13():995618. PubMed ID: 36741012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single versus multiple hyperthermic intraperitoneal chemotherapy applications for T4 gastric cancer patients: Efficacy and safety profiles.
    Zhang J; Sun Y; Bai X; Wang P; Tian L; Tian Y; Zhong Y
    Front Oncol; 2023; 13():1109633. PubMed ID: 37007142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles.
    Zhong Y; Zhang J; Bai X; Sun Y; Liu H; Ma S; Li Y; Kang W; Ma F; Li W; Tian Y
    Cancer Manag Res; 2020; 12():5141-5146. PubMed ID: 32636676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic hyperthermic intraperitoneal chemotherapy for patients with clinical T4 gastric cancer.
    Lee TY; Hsu CH; Fan HL; Liao GS; Chen TW; Chan DC
    Eur J Surg Oncol; 2022 Sep; 48(9):1972-1979. PubMed ID: 35508455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safety evaluation of hyperthermic intraperitoneal chemotherapy in patients with local advanced gastric cancer after radical resection for prevention of peritoneal metastasis].
    Lin Y; Shen C; Guo XK; Li Y; Wang DD; Chen X; Wang Z; Wu K; Tao KX; Wu CQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):48-55. PubMed ID: 35067034
    [No Abstract]   [Full Text] [Related]  

  • 6. The safety and effectiveness of prophylactic hyperthermic intraperitoneal chemotherapy in patients with pathological T3-4 locally advanced colon cancer.
    Mo T; Wen X; Hu T; Zhang Z; Shi Y; Chen Y; Xiang H; Huang J; Xian Z; He X
    Asian J Surg; 2024 Nov; 47(11):4717-4724. PubMed ID: 38604861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobaplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastasis from Appendiceal and Colorectal Cancer: Safety and Efficacy Profiles.
    Pei W; Zhou S; Zhang J; Zhou H; Chen H; Bi J; Zheng Z; Liu Z; Jiang Z; Wang Z; Liu Q; Wang X; Liang J; Feng Q
    Cancer Manag Res; 2020; 12():12099-12110. PubMed ID: 33262658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
    Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
    Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer: A Comparative Nonrandomized Study.
    Bazarbashi S; Badran A; Gad AM; Aljubran A; Alzahrani A; Alshibani A; Alrakaf R; Elhassan T; Alsuhaibani A; Elshenawy MA
    Ann Surg Oncol; 2023 Jan; 30(1):426-432. PubMed ID: 36042103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The safety and efficacy of prophylactic hyperthermic intraperitoneal chemotherapy for elderly patients with locally advanced gastric cancer: a propensity score matching analysis].
    Yu T; Ma FH; An Q; Cao XL; Xiao G; Wu GJ
    Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(36):2867-2873. PubMed ID: 37726993
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)-a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICO.
    Di Giorgio A; Gerardi C; Abatini C; Melotti G; Bonavina L; Torri V; Santullo F; Garattini S; De Luca M; Rulli E; Rulli E; Pacelli F;
    Trials; 2022 Dec; 23(1):969. PubMed ID: 36457115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
    Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
    World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive intraperitoneal hyperthermic perfusion chemotherapy for patients with T4 stage colon adenocarcinoma.
    Li T; Yu J; Chen Y; Liu R; Li Y; Wang YX; Wang JJ; Zhu P
    Tech Coloproctol; 2021 Jun; 25(6):683-691. PubMed ID: 32572664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer.
    Xie TY; Wu D; Li S; Qiu ZY; Song QY; Guan D; Wang LP; Li XG; Duan F; Wang XX
    World J Gastrointest Oncol; 2020 Jul; 12(7):782-790. PubMed ID: 32864045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center.
    Wu HT; Peng KW; Ji ZH; Sun JH; Zhang Q; Yang XJ; Huang CQ; Li Y
    Eur J Surg Oncol; 2016 Jul; 42(7):1024-34. PubMed ID: 27179924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 17. [Safety of patients undergoing radical resection combined with paclitaxel-based hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer].
    Mei JX; Zhao LY; Zhang WH; Liu K; Chen XL; Yang K; Hu JK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):471-477. PubMed ID: 38778687
    [No Abstract]   [Full Text] [Related]  

  • 18. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
    Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y
    Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Study of Short-Term Efficacy and Safety of Mitomycin versus Lobaplatin for Hyperthermic Intraperitoneal Chemotherapy after Radical Surgery in Colorectal Cancer with High-Risk Factors for Peritoneal Carcinomatosis: A Propensity Score Matching Analysis.
    Guo X; Lin Y; Shen C; Li Y; Xiang F; Ruan T; Zeng X; Lv J; Tao K; Wu C
    Curr Oncol; 2023 Jan; 30(2):1488-1501. PubMed ID: 36826075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery.
    Fan B; Bu Z; Zhang J; Zong X; Ji X; Fu T; Jia Z; Zhang Y; Wu X
    BMC Cancer; 2021 Mar; 21(1):216. PubMed ID: 33653317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.